ایمیپنم/سیلاستاتین/رلباکتام (Persian Wikipedia)
Analysis of information sources in references of the Wikipedia article "ایمیپنم/سیلاستاتین/رلباکتام" in Persian language version.
refsWebsite
Global rank
Persian rank
1st place
1st place
drugs.com
- "Cilastatin / imipenem / relebactam (Recarbrio) Use During Pregnancy". Drugs.com. 28 February 2020. Retrieved 1 March 2020.
- "Recarbrio (imipenem, cilastatin, and relebactam) FDA Approval History". Drugs.com. 21 July 2019. Retrieved 20 November 2019.
europa.eu
ema.europa.eu
- "Recarbrio EPAR". آژانس دارویی اروپا (EMA). 10 December 2019. Retrieved 1 March 2020.
fda.gov
fda.gov
- "FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections" (Press release). 17 July 2019. Archived from the original on 20 November 2019. Retrieved 20 November 2019.
This article incorporates text from this source, which is in the public domain. - "Drug Trial Snapshot: Recarbrio". U.S. سازمان غذا و دارو (آمریکا) (FDA). 2 August 2019. Archived from the original on 20 November 2019. Retrieved 20 November 2019.} This article incorporates text from this source, which is in the public domain.
accessdata.fda.gov
- "Drug Approval Package: Recarbrio". U.S. Food and Drug Administration (FDA). 22 July 2019. Retrieved 1 March 2020.
nih.gov
dailymed.nlm.nih.gov
- "Recarbrio- imipenem anhydrous, cilastatin, and relebactam anhydrous injection, powder, for solution". DailyMed. 4 December 2019. Retrieved 1 March 2020.
web.archive.org
- "FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections" (Press release). 17 July 2019. Archived from the original on 20 November 2019. Retrieved 20 November 2019. This article incorporates text from this source, which is in the public domain.
- "Drug Trial Snapshot: Recarbrio". U.S. سازمان غذا و دارو (آمریکا) (FDA). 2 August 2019. Archived from the original on 20 November 2019. Retrieved 20 November 2019.} This article incorporates text from this source, which is in the public domain.